Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Zealand Pharma
  4. Zealand Pharma — November 2021

Zealand Pharma — November 2021

Planlagt Fastgjort Låst Flyttet Zealand Pharma
116 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #105

    "Danske Bank har sænket kursmålet for Zealand Pharma-aktien til 250 kr. mod tidligere 310 kr. Banken fastholder imidlertid sin køb-anbefaling på aktien."

    "De lavere forventninger har ført til en lignende reaktion hos Nordea. Banken sænkede torsdag sit kursmål for den danske biotekaktie – fra 280 kr. til 254 kr. Nordea fastholder dog ligesom Danske Bank sin købsanbefaling på aktien."

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #106

      Det er selvfølgelig ikke sikkert at Danske Bank og Nordea og har ret i deres antagelser, men måske en ide at tage bestik og sagte sigte og sætte kursen 🙂 🙂

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #107

        Xeris Biopharma q3 2021: "Gvoke: Third quarter 2021 prescriptions topped 27,000 for the first time, growing more than 28% from the prior quarter and 95% compared to the same period in 2020. Gvoke’s NRx share of the retail glucagon market grew to approximately 18% during the third quarter. Gvoke YTD revenue more than doubled to $27.9 million when compared to the same nine-month period in 2020."

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #108

          Salget af Gvoke er ved at komme op i fart, monstro at Zegalogue også finder sin plads i det voksende nødpen-marked.

          1 Reply Last reply
          0
          • T Offline
            T Offline
            TopPhama
            wrote on sidst redigeret af
            #109

            hej exitnu kan det ikke passe at Zealand Parma har en Priority Review Voucher?

            1 Reply Last reply
            0
            • T Offline
              T Offline
              TopPhama
              wrote on sidst redigeret af
              #110

              F
              ra analysen Q3: FDA har tildelt orphan drug designation, hvilket giver skattefordele, kan give en længere årrække med eksklusivitet
              efter en produktgodkendelse, udstedelse af en Priority Review Voucher, statslige tilskud m.m. Der er virkelig behov for nyskabelse til
              gavn for de berørte patienter, og glepaglutide kan blive en game-changer

              1 Reply Last reply
              0
              • exitnuE Offline
                exitnuE Offline
                exitnu
                wrote on sidst redigeret af
                #111

                Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021

                Link Preview Image
                Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021

                Company announcement – No. 71 / 2021 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021 Copenhagen, DK and Boston, MA, November...

                favicon

                GlobeNewswire News Room (www.globenewswire.com)

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #112

                  "Following the acquisition of shares in Zealand, Credit Suisse Group AG controls more than 5% of the total voting rights in Zealand and Credit Suisse Group AG holds more than 5% of the total share capital of Zealand."

                  1 Reply Last reply
                  0
                  • SvingtraderenS Offline
                    SvingtraderenS Offline
                    Svingtraderen
                    wrote on sidst redigeret af
                    #113

                    Du er hurtig - tak

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #114

                      @TopPhama - Orphan Drug Designation

                      "Glepaglutide is a long-acting GLP-2 analog in development for the treatment of SBS. It was granted orphan drug designation by the U.S. FDA and is currently being studied in Phase 3 clinical trials"

                      Blocked

                      Short description

                      favicon

                      (www.zealandpharma.com)

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #115

                        @Svingtraderen - tak selv 🙂

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          deleted-user
                          wrote on sidst redigeret af
                          #116

                          Credit Suisse som storaktionær? Ja, hvorfor ikke. Hvis de kan spotte et potentiale og en pris, der danner base for en investering, er de velkommen i familien.

                          1 Reply Last reply
                          0
                          • D Offline
                            D Offline
                            deleted-user
                            wrote on sidst redigeret af
                            #117

                            Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021

                            1 Reply Last reply
                            0

                            Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                            Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                            With your input, this post could be even better 💗

                            Tilmeld Log ind
                            Svar
                            • Svar som emne
                            Login for at svare
                            • Ældste til nyeste
                            • Nyeste til ældste
                            • Most Votes


                            • Log ind

                            • Har du ikke en konto? Tilmeld

                            • Login or register to search.
                            Powered by NodeBB Contributors
                            • First post
                              Last post
                            0
                            • Kategorier
                            • Seneste
                            • Etiketter
                            • Populære
                            • Verden
                            • Bruger
                            • Grupper